Pharmacy Department, Children's Hospital Colorado, Aurora.
J Pediatric Infect Dis Soc. 2019 Mar 28;8(1):69-72. doi: 10.1093/jpids/pix103.
Concomitant administration of enteral fluoroquinolones (FQs) with divalent or trivalent cation-containing compounds results in a reduction in FQ bioavailability. A review of enteral FQ administration with regards to the timing of divalent or trivalent cation-containing compounds in pediatric patients revealed a high number of inappropriately administered FQs. Suggestions for reducing the number of inappropriately timed FQ administrations are presented here.
与含有二价或三价阳离子的化合物同时给予肠内氟喹诺酮(FQs)会导致 FQ 生物利用度降低。回顾儿科患者中含有二价或三价阳离子的化合物给予时间与肠内 FQ 给药的关系,发现大量 FQ 给药时机不当。本文提出了减少不当时间给予 FQ 的建议。